|
Congestive
Citations 301-310 of 1406 total displayed.
|
Past content
(since Jan 1999):
|
- Correspondence
Letter by Hammoud et al Regarding Article "Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition"
- Ramadan Hammoud, Christopher S. Vaccari, and Bobby V. Khan
Circulation 2007;115:e637, doi:10.1161/CIRCULATIONAHA.107.690362
[Full text]
- Correspondence
Response to Letter Regarding Article, "Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition"
- Daniela Cardinale, Alessandro Colombo, Maria T. Sandri, Giuseppina Lamantia, Nicola Colombo, Maurizio Civelli, Giovanni Martinelli, Carlo M. Cipolla, Fabrizio Veglia, and Cesare Fiorentini
Circulation 2007;115:e638, doi:10.1161/CIRCULATIONAHA.107.695619
[Full text]
- Editorials
Exercise Training in Chronic Heart Failure: How to Harmonize Oxidative Stress, Sympathetic Outflow, and Angiotensin II
- Romualdo Belardinelli
Circulation 2007;115:3042-3044, doi:10.1161/CIRCULATIONAHA.107.709329
[Full text]
- Editorials
Can We IMPROVE-CHF Management By Measuring Natriuretic Peptides?
- Barry Greenberg
Circulation 2007;115:3045-3047, doi:10.1161/CIRCULATIONAHA.107.714998
[Full text]
- Exercise Physiology
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients: A Randomized Study
- Ulrik Wisløff, Asbjørn Støylen, Jan P. Loennechen, Morten Bruvold, Øivind Rognmo, Per Magnus Haram, Arnt Erik Tjønna, Jan Helgerud, Stig A. Slørdahl, Sang Jun Lee, Vibeke Videm, Anja Bye, Godfrey L. Smith, Sonia M. Najjar, Øyvind Ellingsen, and Terje Skjærpe
Circulation 2007;115:3086-3094; published online before print as doi:10.1161/CIRCULATIONAHA.106.675041
[Abstract]
[Full text]
- Heart Failure
N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study
- Gordon W. Moe, Jonathan Howlett, James L. Januzzi, Hanna Zowall for the Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators
Circulation 2007;115:3103-3110; published online before print as doi:10.1161/CIRCULATIONAHA.106.666255
[Abstract]
[Full text]
- Heart Failure
Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program
- Eileen O’Meara, Tim Clayton, Margaret B. McEntegart, John J.V. McMurray, Ileana L. Piña, Christopher B. Granger, Jan Östergren, Eric L. Michelson, Scott D. Solomon, Stuart Pocock, Salim Yusuf, Karl Swedberg, and Marc A. Pfeffer
Circulation 2007;115:3111-3120; published online before print as doi:10.1161/CIRCULATIONAHA.106.673442
[Abstract]
[Full text]
- Articles
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction. The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial
- Wilson S. Colucci, Theodore J. Kolias, Kirkwood F. Adams, William F. Armstrong, Jalal K. Ghali, Stephen S. Gottlieb, Barry Greenberg, Michael I. Klibaner, Marrick L. Kukin, Jennifer E. Sugg on behalf of the REVERT Study Group
Circulation published June 18, 2007, doi:10.1161/CIRCULATIONAHA.106.666016
[Abstract]
- Controversies in Cardiovascular Medicine
Added Benefit of Mineralocorticoid Receptor Blockade in the Primary Prevention of Sudden Cardiac Death
- Bertram Pitt and Geoffrey S. Pitt
Circulation 2007;115:2976-2982, doi:10.1161/CIRCULATIONAHA.106.670109
[Full text]
- Controversies in Cardiovascular Medicine
Uncertainty on the Use of Aldosterone Antagonists for Primary Therapy for Sudden Cardiac Death in the Setting of Implanted Devices
- Robert A. Kloner and David S. Cannom
Circulation 2007;115:2983-2989, doi:10.1161/CIRCULATIONAHA.106.684522
[Full text]
|
|
